Haemonetics Corporation (HAE) vs Neogen Corporation (NEOG)
Haemonetics Corporation and Neogen Corporation are both Medical Devices companies. Haemonetics Corporation is the larger, with a market value of $4.8B against $3.0B — 1.6× the size. Neogen Corporation has negative trailing earnings, so its P/E is not meaningful; Haemonetics Corporation trades at 51.4×. Haemonetics Corporation grew revenue faster over the last twelve months: 0.44% against −2.72%. Haemonetics Corporation has the higher net margin (7.12% vs −0.91%) and the higher return on invested capital (5.62% vs −0.50%). Across the 21 metrics below, Haemonetics Corporation leads on 14 and Neogen Corporation on 7.
Valuation
Profitability
| Metric | HAE | NEOG | Medical Devices median |
|---|---|---|---|
| Gross margin | 59.03% | 46.93% | 56.01% |
| Operating margin | 11.86% | (2.48%) | (15.03%) |
| Net margin | 7.12% | (0.91%) | (20.40%) |
| Free cash flow margin | 21.64% | 3.68% | (7.24%) |
| Return on equity | 11.20% | (0.38%) | (15.32%) |
| Return on assets | 3.99% | (0.23%) | (19.72%) |
| Return on invested capital | 5.62% | (0.50%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack